Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
Ophthalmologist Sonal Tuli, MD, discusses the FDA’s recent approval of teprotumumab for thyroid eye disease and what this new drug adds to the treatment landscape for this condition.
Regina Kosiba, RD, LD, discusses key components of nutrition for bariatric surgery recipients, including special populations, such as athletes, patients who are pregnant, and patients receiving...
Regina Kosiba, RD, LD, discusses key components of nutrition for bariatric surgery recipients, including special populations, such as athletes, patients who are pregnant, and patients receiving...
In this commentary, Brian E. Lacy, MD, PhD, from the Mayo Clinic, describes an holistic approach for managing IBS, how gastroenterologists can approach discussing psychological therapeutic options with...
In this commentary, Vrinda Bhardwaj, MD, from Children’s Hospital Los Angeles, highlights dietary strategies and challenges for the management of eosinophilic esophagitis in children.
In this commentary, Vrinda Bhardwaj, MD, from Children’s Hospital Los Angeles, highlights dietary strategies and challenges for the management of eosinophilic esophagitis in children.
